Management of hereditary angioedema: 2010 Canadian approach

@inproceedings{Bowen2010ManagementOH,
  title={Management of hereditary angioedema: 2010 Canadian approach},
  author={Tom Bowen and John Brosz and Kristylea Brosz and Jacques Hebert and Bruce C Ritchie},
  booktitle={Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology},
  year={2010}
}
C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadian Consensus Conference on the diagnosis, therapy and management of HAE. We have formed the Canadian Hereditary Angioedema Network (CHAEN)/Réseau Canadien d'Angioédème Héréditaire (RCAH) - http://www.haecanada.com to advance care of patients with this disorder in Canada. We here present a… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 13 references

Review of Consensus Approaches to the Diagnosis, Therapy, and Management of Hereditary Angioedema circa

  • T Bowen
  • Immunology Allergy Clin 2010,
  • 2009
2 Excerpts

Similar Papers

Loading similar papers…